Successful radiofrequency ablation therapy for hepatocellular carcinoma in a male patient with early stage primary biliary cirrhosis and positive serum hepatitis B core antibody

Journal of the Chinese Medical Association

Volumn 71, Issue 1, 2008, Pages 40-44

  Su, Chien Wei ^a,b   Wu, Jaw Ching ^a,b   Chiou, Yi You ^a   Tsay, Shyh Haw ^a   Huo, Teh Ia ^a,b   Huang, Yi Hsiang ^a,b   Hung, Hung Hsu ^a   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Primary biliary cirrhosis; Radiofrequency ablation therapy

Indexed keywords

ALKALINE PHOSPHATASE; HEPATITIS B CORE ANTIGEN; MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; PATIENT MONITORING; PRIMARY BILIARY CIRRHOSIS; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; BILIARY CIRRHOSIS; BLOOD; CATHETER ABLATION; LIVER TUMOR; METHODOLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE;

EID: 41649101893     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70071-6     Document Type: Article

References (23)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-73.
2. Heathcote J. The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1997;17:23-33.
3. Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a large cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044-51.
4. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancer 2003;362:53-61.
5. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006;130:715-20.
6. Nakanuma Y, Terada T, Doishita K, Miwa A. Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study. Hepatology 1990;11:1010-6.
7. Krasner N, Johnson PJ, Portmann B, Watkinson G, Macsween RNM, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut 1979;20:255-8.
8. Jones DEJ, Metcalf JV, Collier JD, Bassendine MF, James OFW. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997;26:1138-42.
9. Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 1997;92:676-8.
10. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology 1999;29:1425-8.
11. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-relatcd cirrhosis. Am J Gastroenterol 2001;96:1160-3.
12. Shibuya A, Tanaka K, Miyakawa H, Shibata M, Takatori M, Sekiyama b, Hashimoto N, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002;35:1172-8.
13. Nakahira A, Kubo S, Yamamoto T, Ogawa M, Sakebe K, Tanake S, Uenishi T, et al. Resection of hepatocellular carcinoma arising from primary biliary cirrhosis. J Gastroenterol 2004; 39:302-3.
14. Kadokawa Y, Omagari K, Ohba K, Kitomura S, Ohara H, Takeshima F, Mizuta Y, et al. Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis. Intern Med 2005;44:207-11.
15. Suzuki A, Lymp J, Donlinger J, Mendes F, Angulo P, Lindor K. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. Clin Gastroenterol Heparol 2007; 5:259-64.
16. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-6.
17. Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin Med Assoc 2007;70:141-5.
18. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127:S159-66.
19. Huo TI, Huang YH, Wu JC. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc 2005;68:155-9.
20. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, Chen PJ, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005;242:36-42.
21. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-8.
22. Marrero JA. Heparocellular carcinoma. Curr Opin Gastroenterol 2006;22:248-53.
23. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofirequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-6.